Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 15;6(2):100306.
doi: 10.1016/j.opresp.2024.100306. eCollection 2024 Apr-Jun.

Biologics in COPD

Affiliations
Editorial

Biologics in COPD

Ana L Kersul et al. Open Respir Arch. .
No abstract available

PubMed Disclaimer

References

    1. Agustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Arch Bronconeumol. 2023;59:232–248. - PubMed
    1. Barnes P.J. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi: 10.1016/j.jaci.2016.05.011. Epub 2016 May 27. PMID: 27373322. - DOI - PubMed
    1. de Llano L.P., Cosío B.G., Iglesias A., de Las Cuevas N., Soler-Cataluña J.J., Izquierdo J.L., et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018;13:591–601. - PMC - PubMed
    1. Miravitlles M., Calle M., Molina J., Almagro P., Gómez J.T., Trigueros J.A., et al. Spanish COPD Guidelines (GesEPOC) 2021: updated pharmacological treatment of stable COPD. Arch Bronconeumol. 2022;58:69–81. - PubMed
    1. Fieldes M., Bourguignon C., Assou S., Nasri A., Fort A., Vachier I., et al. Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Res. 2021;7:00437–2020. doi: 10.1183/23120541.00437-2020. PMID: 33855061; PMCID: PMC8039900. - DOI - PMC - PubMed

Publication types

LinkOut - more resources